Who we work with
Whatever role you play in advancing animal health, there’s a way to get involved.
Vets
Pet parents
Partners
Researchers
Veterinary clinicians
Partner with us to develop clinically relevant cancer models from ethically consented samples collected during routine veterinary care. Collaborate with us on comparative oncology research that can improve outcomes for companion animals, generate insights relevant to human cancer and support the development of future veterinary clinical trials.
Biospecimen
Help build clinically relevant models of companion-animal cancer
We partner with veterinary centres to develop patient-derived models from surplus, owner-consented samples collected during routine clinical care. Our initial areas of interest include melanoma, osteosarcoma, lymphoma and hemangiosarcoma. These collaborations support more clinically relevant drug development, comparative oncology research and future veterinary clinical studies.
Clinical trials
Become part of our future
clinical research network
We are building relationships with veterinary referral centres and oncology specialists interested in supporting future field studies. Our initial focus is expected to include canine osteosarcoma and lymphoma once our programmes are ready to progress into the clinic.
Comparative oncology collaborations
Advance cancer
research across species
We collaborate with veterinary clinicians and academic researchers interested in cancers that affect both companion animals and people. Projects may include patient-derived models, drug evaluation, biomarkers, tumour biology, translational research and future clinical studies.
One disease.
Two species. Shared progress.
FAQs
Can my practice contribute samples?
+
Yes. We welcome discussions with referral hospitals, veterinary oncology centres and academic veterinary practices.
What types of collaboration are you looking for?
+
We are interested in clinical, academic and technical collaborations that support Patient Derived model development, drug evaluation, biomarker research and future clinical studies.
Can one of my patients take part in a clinical trial?
+
We are not currently recruiting, but future studies will be run through participating veterinary centres. Details will be shared when trials become available.
Are you interesting in evaluating new treatments for pet patients?
+
Yes. We are interested in oncology candidates with a strong scientific rationale for companion-animal cancer.
Pet parents
Help us advocate for better cancer treatments. Pet parents play an important role in raising awareness of the need for better and more accessible cancer treatments. By supporting comparative oncology research and sharing trusted information, you can help advance new treatment options for future pet patients.
Advocacy
Raise awareness of
comparative oncology
Help us advocate for better treatment options, raise awareness of comparative oncology and connect pets in need with eligible clinical trials.
Taking part in future research
Clinical
trial participation
ValiRx Animal Health is not currently recruiting pets into clinical trials. As our programmes progress, future studies may be run through specialist veterinary hospitals and referral centres.
Future treatment opportunities
Developing tomorrow's veterinary cancer treatments
We are working to adapt promising oncology discoveries for use in companion animals. Our aim is to build the evidence needed to support new veterinary treatments and improve the options available to vets and pet parents.
FAQs
Is ValiRx Animal Health currently recruiting pets into clinical trials?
+
No. We will share details through our website, social media and participating veterinary centres when studies become available.
How could my pet be considered for a future trial?
+
Recruitment would take place through participating veterinary hospitals, with eligibility assessed by the treating veterinary team.
Could my pet contribute a sample for research?
+
In some cases, surplus material left after a necessary diagnostic or treatment procedure may be suitable for research.
Can you advise me about my pet's treatment?
+
We cannot provide individual veterinary advice. Please speak to your veterinary surgeon or veterinary oncologist about diagnosis and treatment.
How can I support your work?
+
You can follow our progress on our website and LinkedIn page. Share our work and help raise awareness of comparative oncology.
Partners
Bring your in-licensing opportunities, academic technologies, or commercialisation ambitions to a partner built to accelerate them.
Academic partnerships
Turn promising research into
real-world impact
We work with academic researchers and institutions to translate scientific discoveries into structured veterinary oncology programmes. Collaborations may include patient-derived models, comparative biology, drug evaluation, biomarkers, grant applications and joint publications.
Asset licensing
Unlock the veterinary potential
of promising oncology assets
We evaluate oncology assets and technologies with the potential to address unmet needs in companion-animal cancer. We welcome opportunities from universities, biotechnology companies and pharmaceutical partners seeking a route into the veterinary market.
Co-development opportunities
Develop promising
programmes together
We work with asset owners, technology providers and commercial partners to build focused development programmes. This may include veterinary indication selection, model generation, efficacy testing, biomarker development, clinical planning and commercial partnering.
FAQs
What types of assets are you interested in?
+
We are interested in oncology drug candidates, biologics and technologies with a strong rationale for companion-animal cancer.
At what stage will you consider an opportunity?
+
We will consider assets at different stages, provided there is enough evidence to support the mechanism and potential veterinary application.
What information should I provide initially?
+
A short non-confidential summary covering the mechanism, target indication, available data, development status and partnering opportunity is usually sufficient.
What can ValiRx Animal Health contribute?
+
We can contribute comparative oncology strategy, patient-derived model development, translational testing, programme management and veterinary partnership development.
What types of co-development structure are possible?
+
Partnerships can be tailored to the opportunity and may include licences, option agreements, shared development programmes, milestones and downstream commercial rights.
How do I invest in ValiRx Animal Health?
+
Please contact us to arrange a confidential discussion about current investment opportunities.
Scientific & research community
Collaborate to advance comparative oncology.
Working together
Shared disease biology across species
We work with researchers across veterinary and human oncology to explore shared disease biology, develop clinically relevant patient-derived models and evaluate new therapeutic approaches.
Areas of collaboration
From research through to publication
Our collaborations may include translational research, biomarker discovery, drug evaluation, data generation, grant applications and joint publications.
Scientific & research community
+
